Market Research Logo

Taiwan Pharmaceuticals & Healthcare Report Q2 2018

Taiwan Pharmaceuticals & Healthcare Report Q2 2018

BMI View:

Despite its small relative size, we remain positive about the Taiwanese pharmaceutical market's short-to-medium termpotential. Key factors supporting the growth of the already strong prescription market segment are a strong preference for patenteddrugs, a mature chronic disease profile and the fact that hospitals act as key points of healthcare access. However, as in otherdeveloped markets, the forecasts remain at downside risk from authorities' attempts to control healthcare expenditure and torationalise access to secondary healthcare services.


BMI Industry View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Market Forecast
Industry Risk/Reward Index
Asia Pacific Pharmaceuticals: Region Characterised By A Mix Of Risks And Rewards
Regulatory Development
Regulatory Review
Industry Trends And Developments
Market Overview
Competitive Landscape
Company Profile
Sanofi
GlaxoSmithKline
Merck & Co
Novartis
Pfizer
ScinoPharm Taiwan
TaiGen
Yung Shin Pharmaceutical
Demographic Forecast
Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report